Newsroom

Learn more about us in our featured news stories and insights into our work

News Press Releases Locus Insights

July 11, 2022

The burden of bloodstream infections (BSIs) in the US

Learn More
July 11, 2022

The burden of hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) in the US

Learn More
May 20, 2022

J&J backed Locus closes $35M financing to push CRISPR-based antibacterial drug into phase 2/3

Learn More
May 18, 2022

RTP’s Locus Biosciences closes $35M Series B, investors include J&J and Tencent

Learn More
May 18, 2022

Locus Biosciences Announces $35 Million Financing

Learn More
April 6, 2022

Bacteriophages

Learn More
April 6, 2022

INDUSTRY MATTERS: LOCUS BIOSCIENCES ENLISTS CRISPR-ENHANCED BACTERIOPHAGES TO COMBAT RESISTANT BACTERIA.

Learn More
April 4, 2022

Bacteriophage (Phage) Therapy

Learn More
April 3, 2022

Locus Biomanufacturing Solutions Facility

Learn More
April 2, 2022

The burden of uncomplicated urinary tract infections (UTIs) in the US

Learn More